Dopamine D-1 and D-2 receptor binding sites in brain samples from depressed suicides and controls

被引:51
作者
Bowden, C
Theodorou, AE
Cheetham, SC
Lowther, S
Katona, CLE
Crompton, MR
Horton, RW
机构
[1] ST GEORGE HOSP, SCH MED, DEPT PHARMACOL & CLIN PHARMACOL, LONDON SW17 0RE, ENGLAND
[2] NE SURREY COLL TECHNOL, FAC SCI & TECHNOL, EPSOM KT17 3DS, SURREY, ENGLAND
[3] KNOLL PHARMACEUT RES & DEV, NOTTINGHAM NG1 1GF, ENGLAND
[4] UCL, SCH MED, DEPT PSYCHIAT, LONDON W1N 8AA, ENGLAND
[5] ST GEORGE HOSP, SCH MED, DEPT FORENS MED, LONDON SW17 0RE, ENGLAND
关键词
dopamine D-1 receptor binding site; dopamine D-2 receptor binding site; depression; suicide; post-mortem brain tissue; antidepressant drug; neuroleptic;
D O I
10.1016/S0006-8993(96)01460-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine D-1 and D-2 receptors were measured (by saturation binding of [H-3]SCH23390 and [H-3]raclopride) in caudate; putamen and nucleus accumbens, obtained at post-mortem from suicide victims with a firm retrospective diagnosis of depression, and matched controls. There were no differences in the number or affinity of D-1 or D-2 receptors between suicides who had been free of antidepressants for at least three months prior to death, and controls. Increased numbers and decreased affinity of D-2 receptors were however found in each brain region of antidepressant-treated suicides. We argue that these increases are related to concurrent treatment with neuroleptics rather than a direct effect of antidepressants. Increased numbers of D-1 receptors in antidepressant-treated suicides were seen only in nucleus accumbens. This increase could not be clearly attributed to neuroleptics and may be related to antidepressant treatment. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 51 条
[1]   DOUBLE-BLIND, PLACEBO-CONTROLLED, FIXED DOSE TRIAL OF MINAPRINE IN PATIENTS WITH MAJOR DEPRESSION [J].
AMSTERDAM, JD ;
DUNNER, DL ;
FABRE, LF ;
KIEV, A ;
RUSH, AJ ;
GOODMAN, LI .
PHARMACOPSYCHIATRY, 1989, 22 (04) :137-143
[2]  
ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193
[3]   CORRELATION BETWEEN CEREBROSPINAL-FLUID AMINE METABOLITES AND PSYCHOMOTOR ACTIVITY IN AFFECTIVE-DISORDERS [J].
BANKI, CM .
JOURNAL OF NEUROCHEMISTRY, 1977, 28 (01) :255-257
[4]  
BERGER PA, 1980, AM J PSYCHIAT, V137, P174
[5]   DETERMINATION OF MONOAMINE AND MONOAMINE METABOLITES IN HUMAN BRAIN - POST-MORTEM STUDIES IN A GROUP OF SUICIDES AND IN A CONTROL GROUP [J].
BESKOW, J ;
GOTTFRIES, CG ;
ROOS, BE ;
WINBLAD, B .
ACTA PSYCHIATRICA SCANDINAVICA, 1976, 53 (01) :7-20
[6]  
BOWERS MB, 1969, INT J NEUROPHARMACOL, V8, P255
[7]   CEREBROSPINAL-FLUID 5-HYDROXYINDOLEACETIC ACID (5HIAA) AND HOMOVANILLIC ACID (HVA) FOLLOWING PROBENECID IN UNIPOLAR DEPRESSIVES TREATED WITH AMITRIPTYLINE [J].
BOWERS, MB .
PSYCHOPHARMACOLOGIA, 1972, 23 (01) :26-&
[8]   NEUROENDOCRINE AND AMINE STUDIES IN AFFECTIVE-ILLNESS [J].
CASPER, RC ;
DAVIS, JM ;
PANDEY, GN ;
GARVER, DL ;
DEKIRMENJIAN, H .
PSYCHONEUROENDOCRINOLOGY, 1977, 2 (02) :105-113
[9]  
CELESIA GG, 1972, DIS NERV SYST, V33, P577
[10]   CORTICOSTEROID AND GROWTH-HORMONE RESPONSES TO METHYLAMPHETAMINE IN DEPRESSIVE-ILLNESS [J].
CHECKLEY, SA .
PSYCHOLOGICAL MEDICINE, 1979, 9 (01) :107-115